Milliman, a premier global consulting and actuarial firm, conducted a thorough review of TailorCare’s proprietary model for estimating the impacts of the company’s musculoskeletal (MSK) management program. Milliman’s report concluded that TailorCare’s methodology for estimating cost impacts is reasonable and consistent with industry practices and standards.
Milliman’s analysis involved a comprehensive review of TailorCare’s MSK care cost impact estimation methodology, data sources, and financial assumptions, as well as detailed examinations into historical claims data, cost-impact projections, and comparative benchmarks. Milliman’s findings concluded that TailorCare’s model is a reasonable methodology for estimating the potential impacts of the TailorCare program on costs.
“We are thrilled to have our MSK cost impacts model reviewed by Milliman, a respected leader in the healthcare and actuarial fields,” said Rachel Winokur, TailorCare CEO and co-founder. “This review by Milliman underscores the appropriateness of our estimation model. Having an independent review means that customers can rely on our projections of their potential savings.”
TailorCare plans to leverage this review to expand its reach and impact, working with more healthcare providers and payers to implement specialty value-based care solutions. The company is committed to ongoing innovation and collaboration to further improve the experience of specialty care for patients, providers, and payers.
To view the report on TailorCare’s MSK cost impacts model, please visit: https://www.milliman.com/en/insight/tailorcare-model-estimating-msk-cost-impacts